A Response Assessment Platform for Development and Validation of Imaging Biomarkers in Oncology

Quantitative imaging biomarkers are increasingly used in both oncology clinical trials and clinical practice aid evaluation of tumor response to novel therapies. To obtain these biomarkers, and to ensure smooth clinical adoption once they have been validated, it is critical to develop reliable compu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hao, Schwartz, Lawrence H., Zhao, Binsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Grapho Publications, LLC 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037929/
https://www.ncbi.nlm.nih.gov/pubmed/30042969
http://dx.doi.org/10.18383/j.tom.2016.00223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037929/
https://www.ncbi.nlm.nih.gov/pubmed/30042969
http://dx.doi.org/10.18383/j.tom.2016.00223

Ejemplares similares